Generali Asset Management SPA SGR Invests $8.11 Million in Colgate-Palmolive (NYSE:CL)

Generali Asset Management SPA SGR acquired a new position in Colgate-Palmolive (NYSE:CLFree Report) in the 4th quarter, Holdings Channel reports. The firm acquired 89,155 shares of the company’s stock, valued at approximately $8,105,000.

Several other large investors also recently made changes to their positions in the business. Mirova US LLC increased its position in shares of Colgate-Palmolive by 16.3% in the fourth quarter. Mirova US LLC now owns 11,849 shares of the company’s stock worth $1,077,000 after acquiring an additional 1,659 shares in the last quarter. Horizon Investments LLC grew its holdings in Colgate-Palmolive by 1.3% during the 4th quarter. Horizon Investments LLC now owns 12,390 shares of the company’s stock valued at $1,120,000 after purchasing an additional 165 shares in the last quarter. Advisors Asset Management Inc. grew its holdings in Colgate-Palmolive by 22.1% during the 4th quarter. Advisors Asset Management Inc. now owns 78,474 shares of the company’s stock valued at $7,134,000 after purchasing an additional 14,210 shares in the last quarter. Mystic Asset Management Inc. grew its holdings in Colgate-Palmolive by 4.5% during the 4th quarter. Mystic Asset Management Inc. now owns 24,135 shares of the company’s stock valued at $2,194,000 after purchasing an additional 1,038 shares in the last quarter. Finally, Axxcess Wealth Management LLC grew its holdings in Colgate-Palmolive by 0.3% during the 4th quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company’s stock valued at $3,526,000 after purchasing an additional 117 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on CL shares. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. JPMorgan Chase & Co. raised their price target on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a report on Friday. Morgan Stanley lowered their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Stifel Nicolaus decreased their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Finally, Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $101.72.

Read Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Trading Up 1.0 %

Shares of NYSE:CL opened at $90.72 on Tuesday. The company has a market cap of $73.62 billion, a PE ratio of 25.77, a P/E/G ratio of 4.20 and a beta of 0.40. The company’s 50-day moving average price is $89.09 and its 200 day moving average price is $94.56. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the firm posted $0.87 EPS. Sell-side analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.